Curing HIV will be harder than curing cancer. Apart from a few 'miracle' cases, antiretrovirals only suppress HIV, they don't ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating ...

today announced the opening of the ACACIA study (Antiretrovirals Combined with Antibodies for HIV-1 Cure in Africa), also ...

HIV is like “a hidden danger,” says James Riley, a microbiologist at the University of Pennsylvania, USA. Even now, decades after the virus was identified, and with antiretroviral drugs allowing us to ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, otherwise known as tigilanol tiglate, may also have immense potential for ...

Participants in ACACIA and PAUSE will undergo an analytic treatment interruption (ATI) – a closely monitored pause in ART. ATIs are an integral part of HIV cure trials, because they enable researchers ...

French biotech Abivax’s might be on a verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.

Under Trump's foreign aid pause, all payments by U.S. Agency for International Development (USAID) stopped on Tuesday - for the first time since the fiscal year began on Oct. 1 - and have not resumed, ...

The CDC on Friday is scrubbing a swath of HIV-related content from the agency’s website as a part of Trump’s broader effort ...